50 results on '"Landay, Alan L."'
Search Results
2. The immunogenicity of an HIV-1 Gag conserved element DNA vaccine in people with HIV and receiving antiretroviral therapy
- Author
-
Jacobson, Jeffrey M., Felber, Barbara K., Chen, Huichao, Pavlakis, George N., Mullins, James I., De Rosa, Stephen C., Kuritzkes, Daniel R., Tomaras, Georgia D., Kinslow, Jennifer, Bao, Yajing, Olefsky, Maxine, Rosati, Margherita, Bear, Jenifer, Heptinstall, Jack R., Zhang, Lu, Sawant, Sheetal, Hannaman, Drew, Laird, Gregory M., Cyktor, Joshua C., Heath, Sonya L., Collier, Ann C., Koletar, Susan L., Taiwo, Babafemi O., Tebas, Pablo, Wohl, David A., Belaunzaran-Zamudio, Pablo F., McElrath, M. Juliana, and Landay, Alan L.
- Published
- 2024
- Full Text
- View/download PDF
3. Gut microbiota, circulating inflammatory markers and metabolites, and carotid artery atherosclerosis in HIV infection
- Author
-
Wang, Zheng, Peters, Brandilyn A., Bryant, MacKenzie, Hanna, David B., Schwartz, Tara, Wang, Tao, Sollecito, Christopher C., Usyk, Mykhaylo, Grassi, Evan, Wiek, Fanua, Peter, Lauren St., Post, Wendy S., Landay, Alan L., Hodis, Howard N., Weber, Kathleen M., French, Audrey, Golub, Elizabeth T., Lazar, Jason, Gustafson, Deborah, Sharma, Anjali, Anastos, Kathryn, Clish, Clary B., Burk, Robert D., Kaplan, Robert C., Knight, Rob, and Qi, Qibin
- Published
- 2023
- Full Text
- View/download PDF
4. Machine learning models based on fluid immunoproteins that predict non-AIDS adverse events in people with HIV
- Author
-
Premeaux, Thomas A., Bowler, Scott, Friday, Courtney M., Moser, Carlee B., Hoenigl, Martin, Lederman, Michael M., Landay, Alan L., Gianella, Sara, and Ndhlovu, Lishomwa C.
- Published
- 2024
- Full Text
- View/download PDF
5. Tryptophan metabolism, gut microbiota, and carotid artery plaque in women with and without HIV infection
- Author
-
Luo, Kai, Wang, Zheng, Peters, Brandilyn A., Hanna, David B., Wang, Tao, Sollecito, Christopher C., Grassi, Evan, Wiek, Fanua, St. Peter, Lauren, Usyk, Mykhaylo, Post, Wendy S., Landay, Alan L., Hodis, Howard N., Weber, Kathleen M., French, Audrey, Topper, Elizabeth F., Lazar, Jason, Gustafson, Deborah, Sharma, Anjali, Anastos, Kathryn, Clish, Clary B., Knight, Rob, Kaplan, Robert C., Burk, Robert D., and Qi, Qibin
- Published
- 2024
- Full Text
- View/download PDF
6. Serotonin reduction in post-acute sequelae of viral infection
- Author
-
Wong, Andrea C., Devason, Ashwarya S., Umana, Iboro C., Cox, Timothy O., Dohnalová, Lenka, Litichevskiy, Lev, Perla, Jonathan, Lundgren, Patrick, Etwebi, Zienab, Izzo, Luke T., Kim, Jihee, Tetlak, Monika, Descamps, Hélène C., Park, Simone L., Wisser, Stephen, McKnight, Aaron D., Pardy, Ryan D., Kim, Junwon, Blank, Niklas, Patel, Shaan, Thum, Katharina, Mason, Sydney, Beltra, Jean-Christophe, Michieletto, Michaël F., Ngiow, Shin Foong, Miller, Brittany M., Liou, Megan J., Madhu, Bhoomi, Dmitrieva-Posocco, Oxana, Huber, Alex S., Hewins, Peter, Petucci, Christopher, Chu, Candice P., Baraniecki-Zwil, Gwen, Giron, Leila B., Baxter, Amy E., Greenplate, Allison R., Kearns, Charlotte, Montone, Kathleen, Litzky, Leslie A., Feldman, Michael, Henao-Mejia, Jorge, Striepen, Boris, Ramage, Holly, Jurado, Kellie A., Wellen, Kathryn E., O’Doherty, Una, Abdel-Mohsen, Mohamed, Landay, Alan L., Keshavarzian, Ali, Henrich, Timothy J., Deeks, Steven G., Peluso, Michael J., Meyer, Nuala J., Wherry, E. John, Abramoff, Benjamin A., Cherry, Sara, Thaiss, Christoph A., and Levy, Maayan
- Published
- 2023
- Full Text
- View/download PDF
7. Tryptophan metabolism, gut microbiota, and carotid artery plaque in women with and without HIV infection
- Author
-
Luo, Kai, Wang, Zheng, Peters, Brandilyn A., Hanna, David B., Wang, Tao, Sollecito, Christopher C., Grassi, Evan, Wiek, Fanua, Peter, Lauren St, Usyk, Mykhaylo, Post, Wendy S., Landay, Alan L., Hodis, Howard N., Weber, Kathleen M., French, Audrey, Golub, Elizabeth T., Lazar, Jason, Gustafson, Deborah, Sharma, Anjali, Anastos, Kathryn, Clish, Clary B., Knight, Rob, Kaplan, Robert C., Burk, Robert D., and Qi, Qibin
- Published
- 2023
- Full Text
- View/download PDF
8. Single cell transcriptomics and TCR reconstruction reveal CD4 T cell response to MHC-II-restricted APOB epitope in human cardiovascular disease
- Author
-
Saigusa, Ryosuke, Roy, Payel, Freuchet, Antoine, Gulati, Rishab, Ghosheh, Yanal, Armstrong Suthahar, Sujit Silas, Durant, Christopher P., Hanna, David B., Kiosses, William B., Orecchioni, Marco, Wen, Lai, Wu, Runpei, Kuniholm, Mark H., Landay, Alan L., Anastos, Kathryn, Tien, Phyllis C., Gange, Stephen J., Kassaye, Seble, Vallejo, Jenifer, Hedrick, Catherine C., Kwok, William W., Sette, Alessandro, Hodis, Howard N., Kaplan, Robert C., and Ley, Klaus
- Published
- 2022
- Full Text
- View/download PDF
9. Combined protein and transcript single-cell RNA sequencing in human peripheral blood mononuclear cells
- Author
-
Vallejo, Jenifer, Saigusa, Ryosuke, Gulati, Rishab, Armstrong Suthahar, Sujit Silas, Suryawanshi, Vasantika, Alimadadi, Ahmad, Durant, Christopher P., Ghosheh, Yanal, Roy, Payel, Ehinger, Erik, Pattarabanjird, Tanyaporn, Hanna, David B., Landay, Alan L., Tracy, Russell P., Lazar, Jason M., Mack, Wendy J., Weber, Kathleen M., Adimora, Adaora A., Hodis, Howard N., Tien, Phyllis C., Ofotokun, Igho, Heath, Sonya L., Shemesh, Avishai, McNamara, Coleen A., Lanier, Lewis L., Hedrick, Catherine C., Kaplan, Robert C., and Ley, Klaus
- Published
- 2022
- Full Text
- View/download PDF
10. Author Correction: Combined protein and transcript single-cell RNA sequencing in human peripheral blood mononuclear cells
- Author
-
Vallejo, Jenifer, Saigusa, Ryosuke, Gulati, Rishab, Suthahar, Sujit Silas Armstrong, Suryawanshi, Vasantika, Alimadadi, Ahmad, Durant, Christopher P., Ghosheh, Yanal, Roy, Payel, Ehinger, Erik, Pattarabanjird, Tanyaporn, Hanna, David B., Landay, Alan L., Tracy, Russell P., Lazar, Jason M., Mack, Wendy J., Weber, Kathleen M., Adimora, Adaora A., Hodis, Howard N., Tien, Phyllis C., Ofotokun, Igho, Heath, Sonya L., Shemesh, Avishai, McNamara, Coleen A., Lanier, Lewis L., Hedrick, Catherine C., Kaplan, Robert C., and Ley, Klaus
- Published
- 2022
- Full Text
- View/download PDF
11. HIV and comorbidities – the importance of gut inflammation and the kynurenine pathway
- Author
-
MacCann, Rachel, Landay, Alan L., and Mallon, Patrick W.G.
- Published
- 2023
- Full Text
- View/download PDF
12. IL-32 Drives the Differentiation of Cardiotropic CD4+ T Cells Carrying HIV DNA in People With HIV.
- Author
-
Ramani, Hardik, Gosselin, Annie, Bunet, Rémi, Jenabian, Mohammad-Ali, Sylla, Mohamed, Pagliuzza, Amélie, Chartrand-Lefebvre, Carl, Routy, Jean-Pierre, Goulet, Jean-Philippe, Thomas, Réjean, Trottier, Benoit, Martel-Laferrière, Valérie, Fortin, Claude, Chomont, Nicolas, Fromentin, Rémi, Landay, Alan L, Durand, Madeleine, Ancuta, Petronela, El-Far, Mohamed, and Tremblay, Cecile
- Subjects
T cells ,HIV-positive persons ,INTERLEUKIN-32 ,PROTEIN-tyrosine kinases ,IMMUNOLOGIC memory ,VIRAL tropism - Abstract
Interleukin 32 (IL-32) is a potent multi-isoform proinflammatory cytokine, which is upregulated in people with HIV (PWH) and is associated with cardiovascular disease (CVD) risk. However, the impact of IL-32 isoforms on CD4 T-cell cardiotropism, a mechanism potentially contributing to heart inflammation, remains unknown. Here we show that IL-32 isoforms β and γ induce the generation of CCR4
+ CXCR3+ double positive (DP) memory CD4 T-cell subpopulation expressing the tyrosine kinase receptor c-Met, a phenotype associated with heart-homing of T cells. Our ex vivo studies on PWH show that the frequency of DP CD4 T cells is significantly higher in individuals with, compared to individuals without, subclinical atherosclerosis and that DP cells from antiretroviral-naive and treated individuals are highly enriched with HIV DNA. Together, these data demonstrate that IL-32 isoforms have the potential to induce heart-homing of HIV-infected CD4 T cells, which may further aggravate heart inflammation and CVD in PWH. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
13. IL-17A reprograms intestinal epithelial cells to facilitate HIV-1 replication and outgrowth in CD4+ T cells
- Author
-
Wiche Salinas, Tomas Raul, Gosselin, Annie, Raymond Marchand, Laurence, Moreira Gabriel, Etiene, Tastet, Olivier, Goulet, Jean-Philippe, Zhang, Yuwei, Vlad, Dragos, Touil, Hanane, Routy, Jean-Pierre, Bego, Mariana G., El-Far, Mohamed, Chomont, Nicolas, Landay, Alan L., Cohen, Éric A., Tremblay, Cécile, and Ancuta, Petronela
- Published
- 2021
- Full Text
- View/download PDF
14. Gut Microbiota, Plasma Metabolomic Profiles, and Carotid Artery Atherosclerosis in HIV Infection
- Author
-
Wang, Zheng, Peters, Brandilyn A., Usyk, Mykhaylo, Xing, Jiaqian, Hanna, David B., Wang, Tao, Post, Wendy S., Landay, Alan L., Hodis, Howard N., Weber, Kathleen, French, Audrey, Golub, Elizabeth T., Lazar, Jason, Gustafson, Deborah, Kassaye, Seble, Aouizerat, Bradley, Haberlen, Sabina, Malvestutto, Carlos, Budoff, Matthew, Wolinsky, Steven M., Sharma, Anjali, Anastos, Kathryn, Clish, Clary B., Kaplan, Robert C., Burk, Robert D., and Qi, Qibin
- Published
- 2022
- Full Text
- View/download PDF
15. Obesity in HIV infection: host-pathogen interaction
- Author
-
Savinelli, Stefano, Wrigley Kelly, Neil E., Feeney, Eoin R., OʼShea, Donal B., Hogan, Andrew E., Overton, Edgar T., Landay, Alan L., and Mallon, Patrick W.
- Published
- 2022
- Full Text
- View/download PDF
16. Metabolic and inflammatory perturbation of diabetes associated gut dysbiosis in people living with and without HIV infection.
- Author
-
Luo, Kai, Peters, Brandilyn A., Moon, Jee-Young, Xue, Xiaonan, Wang, Zheng, Usyk, Mykhaylo, Hanna, David B., Landay, Alan L., Schneider, Michael F., Gustafson, Deborah, Weber, Kathleen M., French, Audrey, Sharma, Anjali, Anastos, Kathryn, Wang, Tao, Brown, Todd, Clish, Clary B., Kaplan, Robert C., Knight, Rob, and Burk, Robert D.
- Subjects
HIV infections ,DIABETES ,DYSBIOSIS - Abstract
Background: Gut dysbiosis has been linked with both HIV infection and diabetes, but its interplay with metabolic and inflammatory responses in diabetes, particularly in the context of HIV infection, remains unclear. Methods: We first conducted a cross-sectional association analysis to characterize the gut microbial, circulating metabolite, and immune/inflammatory protein features associated with diabetes in up to 493 women (~ 146 with prevalent diabetes with 69.9% HIV +) of the Women's Interagency HIV Study. Prospective analyses were then conducted to determine associations of identified metabolites with incident diabetes over 12 years of follow-up in 694 participants (391 women from WIHS and 303 men from the Multicenter AIDS Cohort Study; 166 incident cases were recorded) with and without HIV infection. Mediation analyses were conducted to explore whether gut bacteria–diabetes associations are explained by altered metabolites and proteins. Results: Seven gut bacterial genera were identified to be associated with diabetes (FDR-q < 0.1), with positive associations for Shigella, Escherichia, Megasphaera, and Lactobacillus, and inverse associations for Adlercreutzia, Ruminococcus, and Intestinibacter. Importantly, the associations of most species, especially Adlercreutzia and Ruminococcus, were largely independent of antidiabetic medications use. Meanwhile, 18 proteins and 76 metabolites, including 3 microbially derived metabolites (trimethylamine N-oxide, phenylacetylglutamine (PAGln), imidazolepropionic acid (IMP)), 50 lipids (e.g., diradylglycerols (DGs) and triradylglycerols (TGs)) and 23 non-lipid metabolites, were associated with diabetes (FDR-q < 0.1), with the majority showing positive associations and more than half of them (59/76) associated with incident diabetes. In mediation analyses, several proteins, especially interleukin-18 receptor 1 and osteoprotegerin, IMP and PAGln partially mediate the observed bacterial genera–diabetes associations, particularly for those of Adlercreutzia and Escherichia. Many diabetes-associated metabolites and proteins were altered in HIV, but no effect modification on their associations with diabetes was observed by HIV. Conclusion: Among individuals with and without HIV, multiple gut bacterial genera, blood metabolites, and proinflammatory proteins were associated with diabetes. The observed mediated effects by metabolites and proteins in genera–diabetes associations highlighted the potential involvement of inflammatory and metabolic perturbations in the link between gut dysbiosis and diabetes in the context of HIV infection. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
17. Distinct intestinal microbial signatures linked to accelerated systemic and intestinal biological aging.
- Author
-
Singh, Shalini, Giron, Leila B., Shaikh, Maliha W., Shankaran, Shivanjali, Engen, Phillip A., Bogin, Zlata R., Bambi, Simona A., Goldman, Aaron R., Azevedo, Joao L. L. C., Orgaz, Lorena, de Pedro, Nuria, González, Patricia, Giera, Martin, Verhoeven, Aswin, Sánchez-López, Elena, Pandrea, Ivona, Kannan, Toshitha, Tanes, Ceylan E., Bittinger, Kyle, and Landay, Alan L.
- Abstract
Background: People living with HIV (PLWH), even when viral replication is controlled through antiretroviral therapy (ART), experience persistent inflammation. This inflammation is partly attributed to intestinal microbial dysbiosis and translocation, which may lead to non-AIDS-related aging-associated comorbidities. The extent to which living with HIV — influenced by the infection itself, ART usage, sexual orientation, or other associated factors — affects the biological age of the intestines is unclear. Furthermore, the role of microbial dysbiosis and translocation in the biological aging of PLWH remains to be elucidated. To investigate these uncertainties, we used a systems biology approach, analyzing colon and ileal biopsies, blood samples, and stool specimens from PLWH on ART and people living without HIV (PLWoH) as controls. Results: PLWH exhibit accelerated biological aging in the colon, ileum, and blood, as measured by various epigenetic aging clocks, compared to PLWoH. Investigating the relationship between microbial translocation and biological aging, PLWH had decreased levels of tight junction proteins in the intestines, along with increased microbial translocation. This intestinal permeability correlated with faster biological aging and increased inflammation. When investigating the relationship between microbial dysbiosis and biological aging, the intestines of PLWH had higher abundance of specific pro-inflammatory bacteria, such as Catenibacterium and Prevotella. These bacteria correlated with accelerated biological aging. Conversely, the intestines of PLWH had lower abundance of bacteria known for producing the anti-inflammatory short-chain fatty acids, such as Subdoligranulum and Erysipelotrichaceae, and these bacteria were associated with slower biological aging. Correlation networks revealed significant links between specific microbial genera in the colon and ileum (but not in feces), increased aging, a rise in pro-inflammatory microbe-related metabolites (e.g., those in the tryptophan metabolism pathway), and a decrease in anti-inflammatory metabolites like hippuric acid. Conclusions: We identified specific microbial compositions and microbiota-related metabolic pathways that are intertwined with intestinal and systemic biological aging. This microbial signature of biological aging is likely reflecting various factors including the HIV infection itself, ART usage, sexual orientation, and other aspects associated with living with HIV. A deeper understanding of the mechanisms underlying these connections could offer potential strategies to mitigate accelerated aging and its associated health complications. 1fCw832AZENtKENNTh8vkG Video Abstract [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
18. Tryptophan metabolism, gut microbiota, and carotid artery plaque in women with and without HIV infection.
- Author
-
Kai Luo, Zheng Wang, Peters, Brandilyn A., Hanna, David B., Wang, Tao, Sollecito, Christopher C., Grassi, Evan, Wiek, Fanua, St Peter, Lauren, Usyk, Mykhaylo, Post, Wendy S., Landay, Alan L., Hodis, Howard N., Weber, Kathleen M., French, Audrey, Topper, Elizabeth F., Lazar, Jason, Gustafson, Deborah, Sharma, Anjali, and Anastos, Kathryn
- Published
- 2024
- Full Text
- View/download PDF
19. Natural killer cells, gamma delta T cells and classical monocytes are associated with systolic blood pressure in the multi-ethnic study of atherosclerosis (MESA)
- Author
-
Delaney, Joseph A. C., Olson, Nels C., Sitlani, Colleen M., Fohner, Alison E., Huber, Sally A., Landay, Alan L., Heckbert, Susan R., Tracy, Russell P., Psaty, Bruce M., Feinstein, Matt, and Doyle, Margaret F.
- Published
- 2021
- Full Text
- View/download PDF
20. Circulating CD4+ TEMRA and CD4+ CD28− T cells and incident diabetes among persons with and without HIV
- Author
-
Bailin, Samuel S., Kundu, Suman, Wellons, Melissa, Freiberg, Matthew S., Doyle, Margaret F., Tracy, Russell P., Justice, Amy C., Wanjalla, Celestine N., Landay, Alan L., So-Armah, Kaku, Mallal, Simon, Kropski, Jonathan A., and Koethe, John R.
- Published
- 2022
- Full Text
- View/download PDF
21. Chronic HIV Infection and Aging: Application of a Geroscience-Guided Approach
- Author
-
Masters, Mary C., Landay, Alan L., Robbins, Paul D., Tchkonia, Tamar, Kirkland, James L., Kuchel, George A., Niedernhofer, Laura J., and Palella, Frank J.
- Published
- 2022
- Full Text
- View/download PDF
22. Alterations in Th17 Cells and Non-Classical Monocytes as a Signature of Subclinical Coronary Artery Atherosclerosis during ART-Treated HIV-1 Infection.
- Author
-
Wiche Salinas, Tomas Raul, Zhang, Yuwei, Gosselin, Annie, Rosario, Natalia Fonseca, El-Far, Mohamed, Filali-Mouhim, Ali, Routy, Jean-Pierre, Chartrand-Lefebvre, Carl, Landay, Alan L., Durand, Madeleine, Tremblay, Cécile L., and Ancuta, Petronela
- Subjects
T helper cells ,CORONARY artery disease ,MONOCYTES ,CORONARY arteries ,DISEASE risk factors ,HIV - Abstract
Cardiovascular disease (CVD) remains an important comorbidity in people living with HIV-1 (PLWH) receiving antiretroviral therapy (ART). Our previous studies performed in the Canadian HIV/Aging Cohort Study (CHACS) (>40 years-old; Framingham Risk Score (FRS) > 5%) revealed a 2–3-fold increase in non-calcified coronary artery atherosclerosis (CAA) plaque burden, measured by computed tomography angiography scan (CTAScan) as the total (TPV) and low attenuated plaque volume (LAPV), in ART-treated PLWH (HIV+) versus uninfected controls (HIV−). In an effort to identify novel correlates of subclinical CAA, markers of intestinal damage (sCD14, LBP, FABP2); cell trafficking/inflammation (CCL20, CX3CL1, MIF, CCL25); subsets of Th17-polarized and regulatory (Tregs) CD4
+ T-cells, classical/intermediate/non-classical monocytes, and myeloid/plasmacytoid dendritic cells were studied in relationship with HIV and TPV/LAPV status. The TPV detection/values coincided with higher plasma sCD14, FABP2, CCL20, MIF, CX3CL1, and triglyceride levels; lower Th17/Treg ratios; and classical monocyte expansion. Among HIV+ , TPV+ versus TPV− exhibited lower Th17 frequencies, reduced Th17/Treg ratios, higher frequencies of non-classical CCR9low HLADRhigh monocytes, and increased plasma fibrinogen levels. Finally, Th17/Treg ratios and non-classical CCR9low HLADRhigh monocyte frequencies remained associated with TPV/LAPV after adjusting for FRS and HIV/ART duration in a logistic regression model. These findings point to Th17 paucity and non-classical monocyte abundance as novel immunological correlates of subclinical CAA that may fuel the CVD risk in ART-treated PLWH. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
23. Can statin preventative treatment inform geroscience‐guided therapeutics?
- Author
-
Guaraldi, Giovanni, Erlandson, Kristine M., Milic, Jovana, Landay, Alan L., and Montano, Monty A.
- Subjects
STATINS (Cardiovascular agents) ,MAJOR adverse cardiovascular events ,PITAVASTATIN ,THERAPEUTICS ,HIV-positive persons - Abstract
The article discusses the potential benefits of statin treatment in preventing and reducing frailty, particularly in people with HIV (PWH) who are at a higher risk of cardiovascular disease (CVD) and accelerated aging. The REPRIEVE study, which focused on PWH without pre-existing CVD, found that treatment with pitavastatin reduced the risk of major adverse cardiovascular events (MACE) compared to a placebo. The study suggests that statins may have a geroprotective effect by targeting senescence, a key factor in age-related conditions. However, it also acknowledges the potential adverse effects of statins and the need for further research on their mechanisms of action. The findings from the REPRIEVE study may lead to earlier initiation of statin therapy in PWH and have implications for geroscience-guided therapeutics. [Extracted from the article]
- Published
- 2023
- Full Text
- View/download PDF
24. Impact of aging on immunity in the context of COVID-19, HIV, and tuberculosis.
- Author
-
Grifoni, Alba, Alonzi, Tonino, Alter, Galit, Noonan, Douglas McClain, Landay, Alan L., Albini, Adriana, and Goletti, Delia
- Subjects
OLDER people ,TUBERCULOSIS ,AGING ,COVID-19 ,HIV - Abstract
Knowledge of aging biology needs to be expanded due to the continuously growing number of elderly people worldwide. Aging induces changes that affect all systems of the body. The risk of cardiovascular disease and cancer increases with age. In particular, the age-induced adaptation of the immune system causes a greater susceptibility to infections and contributes to the inability to control pathogen growth and immune-mediated tissue damage. Since the impact of aging on immune function, is still to be fully elucidated, this review addresses some of the recent understanding of age-related changes affecting key components of immunity. The emphasis is on immunosenescence and inflammaging that are impacted by common infectious diseases that are characterized by a high mortality, and includes COVID-19, HIV and tuberculosis. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
25. HIV infection and cardiovascular disease have both shared and distinct monocyte gene expression features: Women's Interagency HIV study.
- Author
-
Lin, Juan, Ehinger, Erik, Hanna, David B., Qi, Qibin, Wang, Tao, Ghosheh, Yanal, Mueller, Karin, Anastos, Kathryn, Lazar, Jason M., Mack, Wendy J., Tien, Phyllis C., Berman, Joan W., Cohen, Mardge H., Ofotokun, Igho, Gange, Stephen, Liu, Chenglong, Heath, Sonya L., Tracy, Russell P., Hodis, Howard N., and Landay, Alan L.
- Subjects
HIV infections ,GENE expression ,MONONUCLEAR leukocytes ,HIV ,CAROTID artery ultrasonography - Abstract
Persistent inflammation contributes to the development of cardiovascular disease (CVD) as an HIV-associated comorbidity. Innate immune cells such as monocytes are major drivers of inflammation in men and women with HIV. The study objectives are to examine the contribution of circulating non-classical monocytes (NCM, CD14
dim CD16+ ) and intermediate monocytes (IM, CD14+ CD16+ ) to the host response to long-term HIV infection and HIV-associated CVD. Women with and without chronic HIV infection (H) were studied. Subclinical CVD (C) was detected as plaques imaged by B-mode carotid artery ultrasound. The study included H-C-, H+C-, H-C+, and H+C+ participants (23 of each, matched on race/ethnicity, age and smoking status), selected from among enrollees in the Women's Interagency HIV Study. We assessed transcriptomic features associated with HIV or CVD alone or comorbid HIV/CVD comparing to healthy (H-C-) participants in IM and NCM isolated from peripheral blood mononuclear cells. IM gene expression was little affected by HIV alone or CVD alone. In IM, coexisting HIV and CVD produced a measurable gene transcription signature, which was abolished by lipid-lowering treatment. In NCM, versus non-HIV controls, women with HIV had altered gene expression, irrespective of whether or not they had comorbid CVD. The largest set of differentially expressed genes was found in NCM among women with both HIV and CVD. Genes upregulated in association with HIV included several potential targets of drug therapies, including LAG3 (CD223). In conclusion, circulating monocytes from patients with well controlled HIV infection demonstrate an extensive gene expression signature which may be consistent with the ability of these cells to serve as potential viral reservoirs. Gene transcriptional changes in HIV patients were further magnified in the presence of subclinical CVD. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
26. Differential Impact of IL-32 Isoforms on the Functions of Coronary Artery Endothelial Cells: A Potential Link with Arterial Stiffness and Atherosclerosis.
- Author
-
Bunet, Rémi, Roy-Cardinal, Marie-Hélène, Ramani, Hardik, Cleret-Buhot, Aurélie, Durand, Madeleine, Chartrand-Lefebvre, Carl, Routy, Jean-Pierre, Thomas, Réjean, Trottier, Benoît, Ancuta, Petronela, Hanna, David B., Landay, Alan L., Cloutier, Guy, Tremblay, Cécile L., and El-Far, Mohamed
- Subjects
ARTERIAL diseases ,CORONARY arteries ,ENDOTHELIAL cells ,ENDOTHELIUM diseases ,INTERLEUKIN-32 ,ATHEROSCLEROSIS - Abstract
Chronic inflammation is associated with higher risk of cardiovascular disease (CVD) in people living with HIV (PLWH). We have previously shown that interleukin-32 (IL-32), a multi-isoform proinflammatory cytokine, is chronically upregulated in PLWH and is linked with CVD. However, the mechanistic roles of the different IL-32 isoforms in CVD are yet to be identified. In this study, we aimed to investigate the potential impact of IL-32 isoforms on coronary artery endothelial cells (CAEC), whose dysfunction represents a major factor for atherosclerosis. Our results demonstrated that the predominantly expressed IL-32 isoforms (IL-32β and IL-32γ) have a selective impact on the production of the proinflammatory cytokine IL-6 by CAEC. Furthermore, these two isoforms induced endothelial cell dysfunction by upregulating the expression of the adhesion molecules ICAM-I and VCAM-I and the chemoattractants CCL-2, CXCL-8 and CXCL-1. IL-32-mediated expression of these chemokines was sufficient to drive monocyte transmigration in vitro. Finally, we demonstrate that IL-32 expression in both PLWH and controls correlates with the carotid artery stiffness, measured by the cumulated lateral translation. These results suggest a role for IL-32-mediated endothelial cell dysfunction in dysregulation of the blood vessel wall and that IL-32 may represent a therapeutic target to prevent CVD in PLWH. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
27. Elevated CD4 + T-cell glucose metabolism in HIV+ women with diabetes mellitus.
- Author
-
Butterfield, Tiffany R., Hanna, David B., Kaplan, Robert C., Xue, Xiaonan, Kizer, Jorge R., Durkin, Helen G., Kassaye, Seble G., Nowicki, Marek, Tien, Phyllis C., Topper, Elizabeth T., Floris-Moore, Michelle A., Titanji, Kehmia, Fischl, Margaret A., Heath, Sonya, Palmer, Clovis S., Landay, Alan L., and Anzinger, Joshua J.
- Published
- 2022
- Full Text
- View/download PDF
28. A Summary of the Sixth International Workshop on Microbiome in HIV Pathogenesis, Prevention, and Treatment.
- Author
-
Sherrill-Mix, Scott, Yang, Michelle, Aldrovandi, Grace M., Brenchley, Jason M., Bushman, Frederic D., Collman, Ronald G., Dandekar, Satya, Klatt, Nichole R., Lagenaur, Laurel A., Landay, Alan L., Paredes, Roger, Tachedjian, Gilda, Turpin, Jim A., Serrano-Villar, Sergio, Lozupone, Catherine A., and Ghosh, Mimi
- Published
- 2022
- Full Text
- View/download PDF
29. Monitoring Circulating Immune Checkpoint Proteins as Predictors of Non-AIDS Morbid Events in People With HIV Initiating Antiretroviral Therapy.
- Author
-
Premeaux, Thomas A, Moser, Carlee B, McKhann, Ashley, Hoenigl, Martin, Yeung, Stephen T, Pang, Alina P S, Corley, Michael J, Lederman, Michael M, Landay, Alan L, Gianella, Sara, and Ndhlovu, Lishomwa C
- Subjects
IMMUNE checkpoint proteins ,HIV-positive persons ,ANTIRETROVIRAL agents ,IMMUNE reconstitution inflammatory syndrome ,HIV infections ,STROKE ,LOGISTIC regression analysis - Abstract
Background Although cell surface immune checkpoint proteins (ICPs) such as PD-1 expressed on T cells are associated with T-cell exhaustion, HIV disease progression, and AIDS events, they have shown limited utility in predicting non-AIDS morbidity. Given that ICPs also exist in soluble forms and are elevated in ART-treated HIV infection, we tested the hypothesis that soluble ICPs may be predictive of non-AIDS events in adults initiating ART. Methods Utilizing a nested case–control study from the AIDS Clinical Trials Group ALLRT cohort, we measured plasma levels of 15 soluble inhibitory and activating ICPs by Luminex. Participants (134 cases, 292 matched controls) were evaluated pre-ART, a year post-ART, and immediately preceding a non-AIDS event, which included myocardial infarction (MI)/stroke, malignancy, serious bacterial infection, and nonaccidental death. Results Conditional logistic regression analysis determined that higher levels of soluble CD27 were associated with increased risk of non-AIDS events at all time points. Higher levels of CD40 at baseline and pre-event and CD80 at pre-event were associated with increased risk of non-AIDS events. Examining specific non-AIDS events, multiple ICPs were associated with malignancy at baseline and pre-event, whereas only higher CD27 levels were associated with increased risk of MI/stroke at year 1 and pre-event. Conclusions While select soluble ICPs were associated with non-AIDS events, CD27 emerged as a consistent marker irrespective of ART. Our data may offer guidance on new targets for early clinical monitoring in people with HIV who remain at greater risk of specific non-AIDS events. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
30. Impaired verbal memory in individuals living with HIV and cocaine dependence.
- Author
-
Nigro, Sarah E., Wu, Minjie, Juliano, Anthony C., Napier, T. Celeste, Landay, Alan L., French, Audrey L., and Yang, Shaolin
- Subjects
COCAINE ,VERBAL memory ,HIV ,HIV-positive persons ,VERBAL learning ,KRUSKAL-Wallis Test - Abstract
Our study aimed to understand the independent and combined effects of cocaine dependence and HIV status across aspects of verbal memory. Our sample consisted of a total of 102 individuals: 28 individuals living with HIV and cocaine dependence (HIV+/CD), 28 individuals who are HIV-negative with cocaine dependence (HIV-/CD), 20 individuals living with HIV without cocaine dependence (HIV+/ND), and 26 individuals who are HIV-negative without cocaine dependence (HIV-/ND). We utilized the Hopkins Verbal Learning Test-Revised Version (HVLT-R) to assess components of verbal memory, including encoding, recall, and recognition. A 2 (HIV: Yes/No) × 2 (Cocaine: Yes/No) MANCOVA on Total and Delayed Recall while controlling for premorbid intelligence was conducted. We used a Kruskal-Wallis H test to examine retrieval and recognition. The combination of HIV and cocaine dependence amplified deficits on Total Recall. We found comparably poor performance across Delayed Recall between all three clinical groups. People living with HIV without cocaine dependence demonstrated intact recognition, whereas those with cocaine dependence had poor recognition. HIV and cocaine both impacted verbal memory. However, there are potential subtle differences in the role cocaine versus HIV has on the memory process. People living with HIV without cocaine dependence recognized significantly more words than they could freely recall. In contrast, cocaine dependence impacted recognition in HIV and non-HIV groups. These performance patterns suggest HIV may be associated with retrieval deficits, whereas cocaine dependence may be associated with encoding deficits. Further research assessing these specific components of the memory process will help clarify these potential differences. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
31. Time to Viral Rebound After Interruption of Modern Antiretroviral Therapies.
- Author
-
Li, Jonathan Z, Aga, Evgenia, Bosch, Ronald J, Pilkinton, Mark, Kroon, Eugène, MacLaren, Lynsay, Keefer, Michael, Fox, Lawrence, Barr, Liz, Acosta, Edward, Ananworanich, Jintanat, Coombs, Robert, Mellors, John W, Landay, Alan L, Macatangay, Bernard, Deeks, Steven, Gandhi, Rajesh T, and Smith, Davey M
- Subjects
HIV infections ,PROTEASE inhibitors ,TIME ,ANTIRETROVIRAL agents ,RNA ,DISEASE relapse - Abstract
Background Development of human immunodeficiency virus (HIV) remission strategies requires precise information on time to HIV rebound after treatment interruption, but there is uncertainty regarding whether modern antiretroviral therapy (ART) regimens and timing of ART initiation may affect this outcome. Methods AIDS Clinical Trials Group (ACTG) A5345 enrolled individuals who initiated ART during chronic or early HIV infection and on suppressive ART for ≥2 years. Participants underwent carefully monitored antiretroviral interruption. ART was restarted upon 2 successive viral loads ≥1000 copies/mL. We compared participants of A5345 with participants of 6 historic ACTG treatment interruption studies. Results Thirty-three chronic-treated and 12 early-treated participants interrupted ART with evaluable time to viral rebound. Median time to viral rebound ≥1000 HIV RNA copies/mL was 22 days. Acute retroviral rebound syndrome was diagnosed in 9% of the chronic-treated and none of the early-treated individuals. All participants of the historic studies were on older protease inhibitor-based regimens, whereas 97% of A5345 participants were on integrase inhibitor-based ART. There were no differences in the timing of viral rebound comparing A5345 versus historic studies. In a combined analysis, a higher percentage of early-treated participants remained off ART at posttreatment interruption week 12 (chronic vs early: 2% vs 9%, P = .0496). One chronic-treated and one early-treated A5345 participant remained off ART for >24 weeks. All participants resuppressed after ART reinitiation. Conclusions Early ART initiation, using either older or newer ART regimens, was associated with a significant delay in the time to HIV rebound after ART interruption, lowering the barrier for HIV remission. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
32. Menopause Is Associated With Immune Activation in Women With HIV.
- Author
-
Peters, Brandilyn A, Xue, Xiaonan, Sheira, Lila A, Qi, Qibin, Sharma, Anjali, Santoro, Nanette, Alcaide, Maria L, Ofotokun, Igho, Adimora, Adaora A, McKay, Heather S, Tien, Phyllis C, Michel, Katherine G, Gustafson, Deborah, Turan, Bulent, Landay, Alan L, Kaplan, Robert C, and Weiser, Sheri D
- Subjects
TUMOR necrosis factor receptors ,HIV ,POSTMENOPAUSE ,MENOPAUSE ,CARRIER proteins - Abstract
Background: Persistent immune activation due to gut barrier dysfunction is a suspected cause of morbidity in HIV, but the impact of menopause on this pathway is unknown.Methods: In 350 women with HIV from the Women's Interagency HIV Study, plasma biomarkers of gut barrier dysfunction (intestinal fatty acid binding protein; IFAB), innate immune activation (soluble CD14 and CD163; sCD14, sCD163), and systemic inflammation (interleukin-6 and tumor necrosis factor receptor 1; IL-6, TNFR1) were measured at 674 person-visits spanning ≤2 years.Results: Menopause (post- vs premenopausal status) was associated with higher plasma sCD14 and sCD163 in linear mixed-effects regression adjusting for age and other covariates (β = 161.89 ng/mL; 95% confidence interval [CI], 18.37-305.41 and 65.48 ng/mL, 95% CI, 6.64-124.33, respectively); but not with plasma IFAB, IL-6, or TNFR1. In piece-wise linear mixed-effects regression of biomarkers on years before/after the final menstrual period, sCD14 increased during the menopausal transition by 250.71 ng/mL per year (95% CI, 16.63-484.79; P = .04), but not in premenopausal or postmenopausal periods.Conclusions: In women with HIV, menopause may increase innate immune activation, but data did not support an influence on the gut barrier or inflammation. Clinical implications of immune activation during menopausal transition warrant further investigation. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
33. Plasma galectin-9 as a predictor of adverse non-AIDS events in persons with chronic HIV during suppressive antiretroviral therapy.
- Author
-
Premeaux, Thomas A., Moser, Carlee B., McKhann, Ashley, Hoenigl, Martin, Laws, Elizabeth I., Aquino, Draven L., Lederman, Michael M., Landay, Alan L., Gianella, Sara, Ndhlovu, Lishomwa C., and Adult Clinical Trials Group NWCS 411 Study Team
- Published
- 2021
- Full Text
- View/download PDF
34. Subclinical Carotid Artery Atherosclerosis Is Associated With Increased Expression of Peripheral Blood IL-32 Isoforms Among Women Living With HIV.
- Author
-
El-Far, Mohamed, Hanna, David B., Durand, Madeleine, Larouche-Anctil, Etienne, Sylla, Mohamed, Chartrand-Lefebvre, Carl, Cloutier, Guy, Goulet, Jean Philippe, Kassaye, Seble, Karim, Roksana, Kizer, Jorge R., French, Audrey L., Gange, Stephen J., Lazar, Jason M., Hodis, Howard N., Routy, Jean-Pierre, Ancuta, Petronela, Chomont, Nicolas, Landay, Alan L., and Kaplan, Robert C.
- Published
- 2021
- Full Text
- View/download PDF
35. Overt IL-32 isoform expression at intestinal level during HIV-1 infection is negatively regulated by IL-17A.
- Author
-
Moreira Gabriel, Etiene, Wiche Salinas, Tomas Raul, Gosselin, Annie, Larouche-Anctil, Etienne, Durand, Madeleine, Landay, Alan L., El-Far, Mohamed, Tremblay, Cécile L., Routy, Jean-Pierre, and Ancuta, Petronela
- Published
- 2021
- Full Text
- View/download PDF
36. Plasma Citrate and Succinate Are Associated With Neurocognitive Impairment in Older People With HIV.
- Author
-
Hileman, Corrilynn O, Kalayjian, Robert C, Azzam, Sausan, Schlatzer, Daniela, Wu, Kunling, Tassiopoulos, Katherine, Bedimo, Roger, Ellis, Ronald J, Erlandson, Kristine M, Kallianpur, Asha, Koletar, Susan L, Landay, Alan L, Palella, Frank J, Taiwo, Babafemi, Pallaki, Muralidhar, and Hoppel, Charles L
- Subjects
COGNITION disorder risk factors ,HIV-positive persons ,RESEARCH ,WALKING speed ,AGE distribution ,LIQUID chromatography ,CITRATES ,MEDICAL cooperation ,REGRESSION analysis ,RISK assessment ,NEUROPSYCHOLOGICAL tests ,MASS spectrometry ,DESCRIPTIVE statistics ,DISEASE prevalence ,ACYCLIC acids ,LOGISTIC regression analysis ,ODDS ratio ,LONGITUDINAL method - Abstract
Background Neurocognitive impairment (NCI) is associated with monocyte activation in people with HIV (PWH). Activated monocytes increase glycolysis, reduce oxidative phosphorylation, and accumulate citrate and succinate, tricarboxylic acid (TCA) cycle metabolites that promote inflammation—this metabolic shift may contribute to NCI and slowed gait speed in PWH. Methods Plasma citrate and succinate were assayed by liquid chromatography–mass spectrometry from 957 participants upon entry to a multicenter, prospective cohort of older PWH. Logistic, linear, and mixed-effects linear regression models were used to examine associations between entry/baseline TCA cycle metabolites and cross-sectional and longitudinal NCI, neuropsychological test scores (NPZ-4), and gait speed. Results Median age was 51 (range 40–78) years. Each 1 standard deviation (SD) citrate increment was associated with 1.18 higher odds of prevalent NCI at baseline (P =.03), 0.07 SD lower time-updated NPZ-4 score (P =.01), and 0.02 m/s slower time-updated gait speed (P <.0001). Age accentuated these effects. In the oldest age-quartile, higher citrate was associated with 1.64 higher odds of prevalent NCI, 0.17 SD lower NPZ-4, and 0.04 m/s slower gait speed (P ≤.01 for each). Similar associations were apparent with succinate in the oldest age-quintile, but not with gait speed. In participants without NCI at entry, higher citrate predicted a faster rate of neurocognitive decline. Conclusions Higher plasma citrate and succinate are associated with worse cross-sectional and longitudinal measures of neurocognitive function and gait speed that are age-dependent, supporting the importance of altered bioenergetic metabolism in the pathogenesis of NCI in older PWH. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
37. The Hitchhiker Guide to CD4+ T-Cell Depletion in Lentiviral Infection. A Critical Review of the Dynamics of the CD4+ T Cells in SIV and HIV Infection.
- Author
-
Le Hingrat, Quentin, Sereti, Irini, Landay, Alan L., Pandrea, Ivona, and Apetrei, Cristian
- Subjects
HIV infections ,T cells ,SIMIAN immunodeficiency virus ,MUCOUS membranes ,OPPORTUNISTIC infections ,PSYCHONEUROIMMUNOLOGY - Abstract
CD4
+ T-cell depletion is pathognomonic for AIDS in both HIV and simian immunodeficiency virus (SIV) infections. It occurs early, is massive at mucosal sites, and is not entirely reverted by antiretroviral therapy (ART), particularly if initiated when T-cell functions are compromised. HIV/SIV infect and kill activated CCR5-expressing memory and effector CD4+ T-cells from the intestinal lamina propria. Acute CD4+ T-cell depletion is substantial in progressive, nonprogressive and controlled infections. Clinical outcome is predicted by the mucosal CD4+ T-cell recovery during chronic infection, with no recovery occurring in rapid progressors, and partial, transient recovery, the degree of which depends on the virus control, in normal and long-term progressors. The nonprogressive infection of African nonhuman primate SIV hosts is characterized by partial mucosal CD4+ T-cell restoration, despite high viral replication. Complete, albeit very slow, recovery of mucosal CD4+ T-cells occurs in controllers. Early ART does not prevent acute mucosal CD4+ T-cell depletion, yet it greatly improves their restoration, sometimes to preinfection levels. Comparative studies of the different models of SIV infection support a critical role of immune activation/inflammation (IA/INFL), in addition to viral replication, in CD4+ T-cell depletion, with immune restoration occurring only when these parameters are kept at bay. CD4+ T-cell depletion is persistent, and the recovery is very slow, even when both the virus and IA/INFL are completely controlled. Nevertheless, partial mucosal CD4+ T-cell recovery is sufficient for a healthy life in natural hosts. Cell death and loss of CD4+ T-cell subsets critical for gut health contribute to mucosal inflammation and enteropathy, which weaken the mucosal barrier, leading to microbial translocation, a major driver of IA/INFL. In turn, IA/INFL trigger CD4+ T-cells to become either viral targets or apoptotic, fueling their loss. CD4+ T-cell depletion also drives opportunistic infections, cancers, and comorbidities. It is thus critical to preserve CD4+ T cells (through early ART) during HIV/SIV infection. Even in early-treated subjects, residual IA/INFL can persist, preventing/delaying CD4+ T-cell restoration. New therapeutic strategies limiting mucosal pathology, microbial translocation and IA/INFL, to improve CD4+ T-cell recovery and the overall HIV prognosis are needed, and SIV models are extensively used to this goal. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
38. Editorial: Advances in T Cell Therapeutic Vaccines for HIV.
- Author
-
Macatangay, Bernard J. C., Landay, Alan L., Garcia, Felipe, and Rinaldo, Charles R.
- Subjects
AIDS vaccines ,T cells ,IMMUNOTHERAPY ,HIV prevention ,DRUG side effects ,GENETIC vectors - Abstract
HIV, therapeutic vaccine, T cell, HIV remission, immunotherapy In general, these vaccines have been safe and well-tolerated, and some of the vaccine approaches had promising results with regard to increasing HIV-specific T cell immune responses. Keywords: HIV; therapeutic vaccine; T cell; HIV remission; immunotherapy EN HIV therapeutic vaccine T cell HIV remission immunotherapy 1 3 3 05/02/22 20220427 NES 220427 Despite significant advancements in our understanding of HIV persistence and immunology, long-term remission of HIV off antiretroviral therapy (ART) has not been achieved except in a few reported cases ([1]-[3]). [Extracted from the article]
- Published
- 2022
- Full Text
- View/download PDF
39. Pre-pandemic Metabolic Correlates of COVID-19 Severity and Long COVID Incidence in People Living with HIV.
- Author
-
Agrawal P, Giron LB, Singh S, Haw NJ, Goldman AR, Elkaeid M, Macatangay B, Palella FJ, Alcaide ML, Moran CA, Kassaye SG, Erdmann N, Chew KW, Floris-Moore M, Chandran A, Augenbraun MH, Sharma A, Palmer C, Landay AL, Peluso MJ, Keshavarzian A, Brown TT, Tien PC, and Abdel-Mohsen M
- Abstract
Host metabolic dysregulation, especially in tryptophan metabolism, is intricately linked to COVID-19 severity and its post-acute sequelae (Long COVID). People living with HIV (PLWH) experience similar metabolic dysregulation and face an increased risk of developing Long COVID. However, whether pre-existing HIV-associated metabolic dysregulations contribute in predisposing PLWH to severe COVID-19 outcomes remains underexplored. Analyzing pre-pandemic samples from PLWH with documented post-infection outcomes, we found specific metabolic alterations, including increased tryptophan catabolism, predicting an elevated risk of severe COVID-19 and the incidence of Long COVID. These alterations warrant further investigation for their potential prognostic and mechanistic significance in determining COVID-19 complications., (© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.)
- Published
- 2024
- Full Text
- View/download PDF
40. IL-32 Drives the Differentiation of Cardiotropic CD4+ T Cells Carrying HIV DNA in People With HIV.
- Author
-
Ramani H, Gosselin A, Bunet R, Jenabian MA, Sylla M, Pagliuzza A, Chartrand-Lefebvre C, Routy JP, Goulet JP, Thomas R, Trottier B, Martel-Laferrière V, Fortin C, Chomont N, Fromentin R, Landay AL, Durand M, Ancuta P, El-Far M, and Tremblay C
- Subjects
- Humans, Cell Differentiation, DNA, Viral, Male, Female, Adult, Middle Aged, Protein Isoforms genetics, Protein Isoforms metabolism, HIV-1, Interleukins metabolism, Interleukins genetics, CD4-Positive T-Lymphocytes immunology, HIV Infections immunology, HIV Infections virology
- Abstract
Interleukin 32 (IL-32) is a potent multi-isoform proinflammatory cytokine, which is upregulated in people with HIV (PWH) and is associated with cardiovascular disease (CVD) risk. However, the impact of IL-32 isoforms on CD4 T-cell cardiotropism, a mechanism potentially contributing to heart inflammation, remains unknown. Here we show that IL-32 isoforms β and γ induce the generation of CCR4+CXCR3+ double positive (DP) memory CD4 T-cell subpopulation expressing the tyrosine kinase receptor c-Met, a phenotype associated with heart-homing of T cells. Our ex vivo studies on PWH show that the frequency of DP CD4 T cells is significantly higher in individuals with, compared to individuals without, subclinical atherosclerosis and that DP cells from antiretroviral-naive and treated individuals are highly enriched with HIV DNA. Together, these data demonstrate that IL-32 isoforms have the potential to induce heart-homing of HIV-infected CD4 T cells, which may further aggravate heart inflammation and CVD in PWH., Competing Interests: Potential conflicts of interest. All authors: No reported conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed., (© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2024
- Full Text
- View/download PDF
41. Immunoglobulin G N-glycan markers of accelerated biological aging during chronic HIV infection.
- Author
-
Giron LB, Liu Q, Adeniji OS, Yin X, Kannan T, Ding J, Lu DY, Langan S, Zhang J, Azevedo JLLC, Li SH, Shalygin S, Azadi P, Hanna DB, Ofotokun I, Lazar J, Fischl MA, Haberlen S, Macatangay B, Adimora AA, Jamieson BD, Rinaldo C, Merenstein D, Roan NR, Kutsch O, Gange S, Wolinsky SM, Witt MD, Post WS, Kossenkov A, Landay AL, Frank I, Tien PC, Gross R, Brown TT, and Abdel-Mohsen M
- Subjects
- Male, Humans, Female, Immunoglobulin G, Cross-Sectional Studies, Aging, Inflammation complications, Polysaccharides, HIV Infections, Aging, Premature
- Abstract
People living with HIV (PLWH) experience increased vulnerability to premature aging and inflammation-associated comorbidities, even when HIV replication is suppressed by antiretroviral therapy (ART). However, the factors associated with this vulnerability remain uncertain. In the general population, alterations in the N-glycans on IgGs trigger inflammation and precede the onset of aging-associated diseases. Here, we investigate the IgG N-glycans in cross-sectional and longitudinal samples from 1214 women and men, living with and without HIV. PLWH exhibit an accelerated accumulation of pro-aging-associated glycan alterations and heightened expression of senescence-associated glycan-degrading enzymes compared to controls. These alterations correlate with elevated markers of inflammation and the severity of comorbidities, potentially preceding the development of such comorbidities. Mechanistically, HIV-specific antibodies glycoengineered with these alterations exhibit a reduced ability to elicit anti-HIV Fc-mediated immune activities. These findings hold potential for the development of biomarkers and tools to identify and prevent premature aging and comorbidities in PLWH., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
42. A Blood Immunological Signature of Subclinical Coronary Artery Atherosclerosis in People Living with HIV-1 Receiving Antiretroviral Therapy.
- Author
-
Wiche Salinas TR, Zhang Y, Gosselin A, Do Rosario NF, El-Far M, Filali-Mouhim A, Routy JP, Chartrand-Lefebvre C, Landay AL, Durand M, Tremblay CL, and Ancuta P
- Abstract
Cardiovascular disease (CVD) remains an important co-morbidity in people living with HIV-1 (PLWH) receiving antiretroviral therapy (ART). Our previous studies performed on the Canadian HIV/Aging Cohort Study (CHACS) (>40 years-old; Framingham Risk Score (FRS) >5%), revealed a 2-3-fold increase in non-calcified coronary artery atherosclerosis (CAA) plaque burden, measured by Computed tomography angiography scan (CTAScan) as total (TPV) and low attenuated plaque volume (LAPV) in ART-treated PLWH (HIV+) versus uninfected controls (HIV-). In an effort to identify novel correlates of subclinical CAA, markers of intestinal damage (sCD14, LBP, FABP2); cell trafficking/inflammation (CCL20, CX3CL1, MIF, CCL25); subsets of Th17-polarized and regulatory (Tregs) CD4
+ T-cells, classical/intermediate/non-classical monocytes, and myeloid/plasmacytoid dendritic cells, were studied in relationship with HIV and TPV/LAPV status. The TPV detection/values coincided with higher plasma sCD14, FABP2, CCL20, MIF, CX3CL1 and triglyceride levels, lower Th17/Treg ratios, and classical monocyte expansion. Among HIV+ , TPV+ versus TPV- exhibited lower Th17 frequencies, reduced Th17/Treg ratios, higher frequencies of non-classical CCR9low HLADRhigh monocyte, and increased plasma fibrinogen levels. Finally, Th17/Treg ratios and non-classical CCR9low HLADRhigh monocyte frequencies remained associated with TPV/LAPV after adjusting for FRS and HIV/ART duration in a logistic regression model. These findings point to Th17 paucity and non-classical monocyte abundance as novel immunological correlates of subclinical CAA that may fuel the CVD risk in ART-treated PLWH.- Published
- 2023
- Full Text
- View/download PDF
43. Distinct Intestinal Microbial Signatures Linked to Accelerated Biological Aging in People with HIV.
- Author
-
Singh S, Giron LB, Shaikh MW, Shankaran S, Engen PA, Bogin ZR, Bambi SA, Goldman AR, Azevedo JLLC, Orgaz L, de Pedro N, González P, Giera M, Verhoeven A, Sánchez-López E, Pandrea IV, Kannan T, Tanes CE, Bittinger K, Landay AL, Corley MJ, Keshavarzian A, and Abdel-Mohsen M
- Abstract
Background: People with HIV (PWH), even with controlled viral replication through antiretroviral therapy (ART), experience persistent inflammation. This is partly due to intestinal microbial dysbiosis and translocation. Such ongoing inflammation may lead to the development of non-AIDS-related aging-associated comorbidities. However, there remains uncertainty regarding whether HIV affects the biological age of the intestines and whether microbial dysbiosis and translocation influence the biological aging process in PWH on ART. To fill this knowledge gap, we utilized a systems biology approach, analyzing colon and ileal biopsies, blood samples, and stool specimens from PWH on ART and their matched HIV-negative counterparts., Results: Despite having similar chronological ages, PWH on ART exhibit accelerated biological aging in the colon, ileum, and blood, as measured by various epigenetic aging clocks, compared to HIV-negative controls. Investigating the relationship between microbial translocation and biological aging, PWH on ART had decreased levels of tight junction proteins in the colon and ileum, along with increased microbial translocation. This increased intestinal permeability correlated with faster intestinal and systemic biological aging, as well as increased systemic inflammation. When investigating the relationship between microbial dysbiosis and biological aging, the intestines of PWH on ART had higher abundance of specific pro-inflammatory bacterial genera, such as Catenibacterium and Prevotella . These bacteria significantly correlated with accelerated local and systemic biological aging. Conversely, the intestines of PWH on ART had lower abundance of bacterial genera known for producing short-chain fatty acids and exhibiting anti-inflammatory properties, such as Subdoligranulum and Erysipelotrichaceae , and these bacteria taxa were associated with slower biological aging. Correlation networks revealed significant links between specific microbial genera in the colon and ileum (but not in feces), increased aging, a rise in pro-inflammatory microbial-related metabolites (e.g., those in the tryptophan metabolism pathway), and a decrease in anti-inflammatory metabolites like hippuric acid and oleic acid., Conclusions: We identified a specific microbial composition and microbiome-related metabolic pathways that are intertwined with both intestinal and systemic biological aging in PWH on ART. A deeper understanding of the mechanisms underlying these connections could potentially offer strategies to counteract premature aging and its associated health complications in PWH., Competing Interests: Competing interests The authors have no competing interests.
- Published
- 2023
- Full Text
- View/download PDF
44. T cell activation is insufficient to drive SIV disease progression.
- Author
-
Apetrei C, Gaufin T, Brocca-Cofano E, Sivanandham R, Sette P, He T, Sivanandham S, Martinez Sosa N, Martin KJ, Raehtz KD, Kleinman AJ, Valentine A, Krampe N, Gautam R, Lackner AA, Landay AL, Ribeiro RM, and Pandrea I
- Subjects
- Animals, Chlorocebus aethiops, Disease Progression, CD4-Positive T-Lymphocytes, Inflammation, Simian Acquired Immunodeficiency Syndrome, Simian Immunodeficiency Virus
- Abstract
Resolution of T cell activation and inflammation is a key determinant of the lack of SIV disease progression in African green monkeys (AGMs). Although frequently considered together, T cell activation occurs in response to viral stimulation of acquired immunity, while inflammation reflects innate immune responses to mucosal injury. We dissociated T cell activation from inflammation through regulatory T cell (Treg) depletion with Ontak (interleukin-2 coupled with diphtheria toxin) during early SIV infection of AGMs. This intervention abolished control of T cell immune activation beyond the transition from acute to chronic infection. Ontak had no effect on gut barrier integrity, microbial translocation, inflammation, and hypercoagulation, despite increasing T cell activation. Ontak administration increased macrophage counts yet decreased their activation. Persistent T cell activation influenced SIV pathogenesis, shifting the ramp-up in viral replication to earlier time points, prolonging the high levels of replication, and delaying CD4+ T cell restoration yet without any clinical or biological sign of disease progression in Treg-depleted AGMs. Thus, by inducing T cell activation without damaging mucosal barrier integrity, we showed that systemic T cell activation per se is not sufficient to drive disease progression, which suggests that control of systemic inflammation (likely through maintenance of gut integrity) is the key determinant of lack of disease progression in natural hosts of SIVs.
- Published
- 2023
- Full Text
- View/download PDF
45. Characterizing Symptoms and Identifying Biomarkers of Long COVID in People With and Without HIV: Protocol for a Remotely Conducted Prospective Observational Cohort Study.
- Author
-
Márquez NG, Jamal A, Johnston R, Richter EI, Gorbach PM, Vannorsdall TD, Rubin LH, Jennings C, Landay AL, Peluso MJ, and Antar AAR
- Abstract
Background: Living with HIV is a risk factor for severe acute COVID-19, but it is unknown whether it is a risk factor for long COVID., Objective: This study aims to characterize symptoms, sequelae, and cognition formally and prospectively 12 months following SARS-CoV-2 infection in people living with HIV compared with people without HIV. People with no history of SARS-CoV-2 infection, both with and without HIV, are enrolled as controls. The study also aims to identify blood-based biomarkers or patterns of immune dysregulation associated with long COVID., Methods: This prospective observational cohort study enrolled participants into 1 of the following 4 study arms: people living with HIV who had SARS-CoV-2 infection for the first time <4 weeks before enrollment (HIV+COVID+ arm), people without HIV who had SARS-CoV-2 infection for the first time within 4 weeks of enrollment (HIV-COVID+ arm), people living with HIV who believed they never had SARS-CoV-2 infection (HIV+COVID- arm), and people without HIV who believed they never had SARS-CoV-2 infection (HIV-COVID- arm). At enrollment, participants in the COVID+ arms recalled their symptoms, mental health status, and quality of life in the month before having SARS-CoV-2 infection via a comprehensive survey administered by telephone or on the web. All participants completed the same comprehensive survey 1, 2, 4, 6, and 12 months after post-acute COVID-19 symptom onset or diagnosis, if asymptomatic, (COVID+ arms) or after enrollment (COVID- arms) on the web or by telephone. In total, 11 cognitive assessments were administered by telephone at 1 and 4 months after symptom onset (COVID+ arms) or after enrollment (COVID- arms). A mobile phlebotomist met the participants at a location of their choice for height and weight measurements, orthostatic vital signs, and a blood draw. Participants in the COVID+ arms donated blood 1 and 4 months after COVID-19, and participants in the COVID- arms donated blood once or none. Blood was then shipped overnight to the receiving study laboratory, processed, and stored., Results: This project was funded in early 2021, and recruitment began in June 2021. Data analyses will be completed by summer 2023. As of February 2023, a total of 387 participants were enrolled in this study, with 345 participants having completed enrollment or baseline surveys together with at least one other completed study event. The 345 participants includes 76 (22%) HIV+COVID+, 121 (35.1%) HIV-COVID+, 78 (22.6%) HIV+COVID-, and 70 (20.3%) HIV-COVID- participants., Conclusions: This study will provide longitudinal data to characterize COVID-19 recovery over 12 months in people living with and without HIV. Additionally, this study will determine whether biomarkers or patterns of immune dsyregulation associate with decreased cognitive function or symptoms of long COVID., International Registered Report Identifier (irrid): DERR1-10.2196/47079., (©Nuria Gallego Márquez, Armaan Jamal, Rowena Johnston, E India Richter, Pamina M Gorbach, Tracy D Vannorsdall, Leah H Rubin, Cheryl Jennings, Alan L Landay, Michael J Peluso, Annukka A R Antar. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 31.05.2023.)
- Published
- 2023
- Full Text
- View/download PDF
46. T-cell activation state differentially contributes to neuropsychiatric complications in women with HIV.
- Author
-
Williams DW, Flores BR, Xu Y, Wang Y, Yu D, Peters BA, Adedimeji A, Wilson TE, Merenstein D, Tien PC, Cohen MH, Weber KM, Adimora AA, Ofotokun I, Fischl M, Turan J, Turan B, Laumet G, Landay AL, Dastgheyb RM, Gange SJ, Weiser SD, and Rubin LH
- Abstract
Neuropsychiatric complications are common among women with HIV (WWH). The pathophysiological mechanisms underlying these complications are not fully known but likely driven in part by immune modulation. We examined associations between T-cell activation states which are required to mount an effective immune response (activation, co-stimulation/normal function, exhaustion, senescence) and neuropsychiatric complications in WWH. 369 WWH (78% HIV RNA undetectable/<20cp/mL) enrolled in the Women's Interagency HIV Study completed neuropsychological testing and measures of depression (Center for Epidemiological Studies Depression Scale-CES-D), self-reported stress levels (Perceived Stress Scale-10), and post-traumatic stress (PTSD Checklist-Civilian Scale). Multiparametric flow cytometry evaluated T-cell activation state. Partial least squares regressions were used to examine T-cell phenotypes and neuropsychiatric outcome associations after confounder adjustment. In the total sample and among virally suppressed (VS)-WWH, CD4
+ T-cell exhaustion was associated with poorer learning and attention/working memory ( P 's < 0.05). In the total sample, CD4+ T-cell activation was associated with better attention/working memory and CD8+ T-cell co-stimulation and senescence was associated with poorer executive function ( P 's < 0.05). For mental health outcomes, in the total sample, CD4+ T-cell activation was associated with more perceived stress and CD4+ T-cell exhaustion was associated with less depressive symptoms ( P 's < 0.05). Among VS-WWH, CD4+ senescence was associated with less perceive stress and CD8+ T-cell co-stimulation and senescence was associated with higher depression ( P's < 0.05). Together, results suggest the contribution of peripheral CD4+ and CD8+ T-cell activation status to neuropsychiatric complications in WWH., Competing Interests: LHR is a consultant for Digital Artefacts, Inc. All coauthors have nothing to disclose., (© 2022 The Authors. Published by Elsevier Inc.)- Published
- 2022
- Full Text
- View/download PDF
47. Chronic HIV Infection and Aging: Application of a Geroscience-Guided Approach.
- Author
-
Masters MC, Landay AL, Robbins PD, Tchkonia T, Kirkland JL, Kuchel GA, Niedernhofer LJ, and Palella FJ
- Subjects
- Aged, Aging, Comorbidity, Geroscience, Humans, Longevity, HIV Infections drug therapy, HIV Infections epidemiology
- Abstract
Abstract: The ability of virally suppressive antiretroviral therapy use to extend the life span of people with HIV (PWH) implies that the age of PWH will also increase. Among PWH, extended survival comes at a cost of earlier onset and increased rates of aging-associated comorbidities and geriatric syndromes, with persistent inflammation and immune dysregulation consequent to chronic HIV infection and to antiretroviral therapy use contributing to an overall decrease in health span. The geroscience hypothesis proposes that the root causes of most aging-related chronic diseases and conditions is the aging process itself. Hence, therapeutically targeting fundamental aging processes could have a greater impact on alleviating or delaying aging-associated comorbidities than addressing each disease individually. Extending the geroscience hypothesis to PWH, we speculate that targeting basic mechanisms of aging will improve overall health with age. Clinical features and pathophysiologic mechanisms of chronic diseases in PWH qualitatively resemble those seen in older adults without HIV. Therefore, drugs that target any of the pillars of aging, including metformin, rapamycin, and nicotinamide adenine dinucleotide precursors, may also slow the rate of onset of age-associated comorbidities and geriatric syndromes in PWH. Drugs that selectively induce apoptosis of senescent cells, termed senolytics, may also improve health span among PWH. Preliminary evidence suggests that senescent cell burden is increased in PWH, implying that senescent cells are an excellent therapeutic target for extending health span. Recently initiated clinical trials evaluating senolytics in age-related diseases offer insights into the design and potential implementation of similar trials for PWH., Competing Interests: The authors have no conflicts of interest to disclose., (Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
48. Is France Once Again Looking for a Scapegoat?
- Author
-
Lederman MM, Flier JS, Hale P, Haase AT, Powderly W, Reiss P, Silvestri G, Sekaly RP, Paiardini M, Weissman D, Kuritzkes DR, Calabrese LH, Agre P, Reyes-Teran G, Landay AL, Lewin S, Richman DD, Volberding P, Hunt PW, and Schechter M
- Abstract
On September 10, 2021, a special tribunal established by the French government launched an inquiry into the activities of former health minister Dr. Agnes Buzyn who was charged with "endangering the lives of others". It is surprising to learn of this accusation and inquiry into the actions of a public health official whose response to the epidemic was, to all appearances, exemplary., Competing Interests: There are no financial conflicts of interest. Michael Lederman and Peter Hale have had scientific collaborations with Dr. Buzyn's husband Dr. Yves Levy. Sharon Lewin and Guido Silvestri are scientific advisors for the French National Agency for AIDS Research (ANRS)., (Copyright © Pathogens and Immunity 2021.)
- Published
- 2021
- Full Text
- View/download PDF
49. Brief Report: Subclinical Carotid Artery Atherosclerosis Is Associated With Increased Expression of Peripheral Blood IL-32 Isoforms Among Women Living With HIV.
- Author
-
El-Far M, Hanna DB, Durand M, Larouche-Anctil E, Sylla M, Chartrand-Lefebvre C, Cloutier G, Goulet JP, Kassaye S, Karim R, Kizer JR, French AL, Gange SJ, Lazar JM, Hodis HN, Routy JP, Ancuta P, Chomont N, Landay AL, Kaplan RC, and Tremblay CL
- Subjects
- Atherosclerosis metabolism, Biomarkers, Carotid Artery Diseases epidemiology, Case-Control Studies, Cross-Sectional Studies, Female, HIV Infections blood, HIV Infections diagnosis, Humans, Interleukins genetics, Leukocytes, Mononuclear, Middle Aged, Protein Isoforms, RNA, Messenger, Atherosclerosis complications, Carotid Artery Diseases complications, HIV Infections complications, Interleukins metabolism, Plaque, Atherosclerotic
- Abstract
Background: Persistent inflammation in HIV infection is associated with elevated cardiovascular disease (CVD) risk, even with viral suppression. Identification of novel surrogate biomarkers can enhance CVD risk stratification and suggest novel therapies. We investigated the potential of interleukin 32 (IL-32), a proinflammatory multi-isoform cytokine, as a biomarker for subclinical carotid artery atherosclerosis in virologically suppressed women living with HIV (WLWH)., Methods and Results: Nested within the Women's Interagency HIV Study, we conducted a cross-sectional comparison of IL-32 between 399 WLWH and 100 women without HIV, followed by a case-control study of 72 WLWH (36 carotid artery plaque cases vs. 36 age-matched controls without plaque). Plasma IL-32 protein was measured by ELISA, and mRNA of IL-32 isoforms (IL-32α, β, γ, D, ε, and θ) was quantified by reverse transcription polymerase chain reaction from peripheral blood mononuclear cells. Plasma IL-32 protein levels were higher in WLWH compared with women without HIV (P = 0.02). Among WLWH, although plasma IL-32 levels did not differ significantly between plaque cases and controls, expression of IL-32 isoforms α, β, and ε mRNA was significantly higher in peripheral blood mononuclear cells from cases (P = 0.01, P = 0.005, and P = 0.018, respectively). Upregulation of IL-32β and IL-32ε among WLWH with carotid artery plaque persisted after adjustment for age, race/ethnicity, smoking, systolic blood pressure, body mass index, and history of hepatitis C virus (P = 0.04 and P = 0.045); the adjusted association for IL-32α was marginally significant (P = 0.07)., Conclusions: IL-32 isoforms should be studied further as potential CVD biomarkers. This is of particular interest in WLWH by virtue of altered IL-32 levels in this population., Competing Interests: J.R.K. has stock ownership in Bristol-Myers Squibb, Johnson & Johnson, Medtronic, Merck, and Pfizer. The remaining authors have no conflicts of interest to disclose., (Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc.)
- Published
- 2021
- Full Text
- View/download PDF
50. The Hitchhiker Guide to CD4 + T-Cell Depletion in Lentiviral Infection. A Critical Review of the Dynamics of the CD4 + T Cells in SIV and HIV Infection.
- Author
-
Le Hingrat Q, Sereti I, Landay AL, Pandrea I, and Apetrei C
- Subjects
- Animals, Bacterial Translocation, CD4 Lymphocyte Count, CD4-Positive T-Lymphocytes immunology, CD4-Positive T-Lymphocytes metabolism, Gastrointestinal Microbiome, HIV immunology, HIV Infections immunology, HIV Infections metabolism, HIV Infections microbiology, Haplorhini, Host-Pathogen Interactions, Humans, Immunocompromised Host, Inflammation Mediators metabolism, Intestinal Mucosa immunology, Intestinal Mucosa microbiology, Phenotype, Simian Acquired Immunodeficiency Syndrome immunology, Simian Acquired Immunodeficiency Syndrome metabolism, Simian Acquired Immunodeficiency Syndrome microbiology, Simian Immunodeficiency Virus immunology, Time Factors, CD4-Positive T-Lymphocytes virology, HIV pathogenicity, HIV Infections virology, Immunity, Mucosal, Intestinal Mucosa virology, Simian Acquired Immunodeficiency Syndrome virology, Simian Immunodeficiency Virus pathogenicity
- Abstract
CD4
+ T-cell depletion is pathognomonic for AIDS in both HIV and simian immunodeficiency virus (SIV) infections. It occurs early, is massive at mucosal sites, and is not entirely reverted by antiretroviral therapy (ART), particularly if initiated when T-cell functions are compromised. HIV/SIV infect and kill activated CCR5-expressing memory and effector CD4+ T-cells from the intestinal lamina propria. Acute CD4+ T-cell depletion is substantial in progressive, nonprogressive and controlled infections. Clinical outcome is predicted by the mucosal CD4+ T-cell recovery during chronic infection, with no recovery occurring in rapid progressors, and partial, transient recovery, the degree of which depends on the virus control, in normal and long-term progressors. The nonprogressive infection of African nonhuman primate SIV hosts is characterized by partial mucosal CD4+ T-cell restoration, despite high viral replication. Complete, albeit very slow, recovery of mucosal CD4+ T-cells occurs in controllers. Early ART does not prevent acute mucosal CD4+ T-cell depletion, yet it greatly improves their restoration, sometimes to preinfection levels. Comparative studies of the different models of SIV infection support a critical role of immune activation/inflammation (IA/INFL), in addition to viral replication, in CD4+ T-cell depletion, with immune restoration occurring only when these parameters are kept at bay. CD4+ T-cell depletion is persistent, and the recovery is very slow, even when both the virus and IA/INFL are completely controlled. Nevertheless, partial mucosal CD4+ T-cell recovery is sufficient for a healthy life in natural hosts. Cell death and loss of CD4+ T-cell subsets critical for gut health contribute to mucosal inflammation and enteropathy, which weaken the mucosal barrier, leading to microbial translocation, a major driver of IA/INFL. In turn, IA/INFL trigger CD4+ T-cells to become either viral targets or apoptotic, fueling their loss. CD4+ T-cell depletion also drives opportunistic infections, cancers, and comorbidities. It is thus critical to preserve CD4+ T cells (through early ART) during HIV/SIV infection. Even in early-treated subjects, residual IA/INFL can persist, preventing/delaying CD4+ T-cell restoration. New therapeutic strategies limiting mucosal pathology, microbial translocation and IA/INFL, to improve CD4+ T-cell recovery and the overall HIV prognosis are needed, and SIV models are extensively used to this goal., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2021 Le Hingrat, Sereti, Landay, Pandrea and Apetrei.)- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.